Elide Matano

2.0k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Elide Matano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Elide Matano has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Elide Matano's work include Myasthenia Gravis and Thymoma (7 papers), Cancer Treatment and Pharmacology (6 papers) and Pituitary Gland Disorders and Treatments (5 papers). Elide Matano is often cited by papers focused on Myasthenia Gravis and Thymoma (7 papers), Cancer Treatment and Pharmacology (6 papers) and Pituitary Gland Disorders and Treatments (5 papers). Elide Matano collaborates with scholars based in Italy, United States and France. Elide Matano's co-authors include Sabino De Placido, C. Boni, Francesco Di Costanzo, Vincenzo Adamo, Giorgio V. Scagliotti, Monica Rinaldi, Lucio Crinò, Maurizio Tonato, L. Frontini and M. Marangolo and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Elide Matano

46 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

2002 739 citations Elide Matano, C. Boni et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elide Matano Italy	14	907	863	260	228	161	48	1.5k
Giuseppe Fornarini Italy	22	597 0.7×	562 0.7×	305 1.2×	245 1.1×	166 1.0×	125	1.3k
Lina Tang China	23	831 0.9×	645 0.7×	150 0.6×	446 2.0×	171 1.1×	73	1.6k
Tracy Proverbs‐Singh United States	7	688 0.8×	268 0.3×	116 0.4×	210 0.9×	75 0.5×	14	1.1k
Stefano Cereda Italy	21	1.1k 1.2×	535 0.6×	564 2.2×	313 1.4×	323 2.0×	53	1.5k
Leyla Kılıç Türkiye	17	545 0.6×	348 0.4×	162 0.6×	110 0.5×	136 0.8×	50	978
Mario V. Fiorentino Italy	23	554 0.6×	452 0.5×	278 1.1×	320 1.4×	298 1.9×	80	1.7k
Enrique González‐Billalabeitia Spain	19	580 0.6×	365 0.4×	154 0.6×	527 2.3×	399 2.5×	75	1.3k
L. Falchero France	18	673 0.7×	1.0k 1.2×	127 0.5×	172 0.8×	118 0.7×	71	1.4k
Ulrich‐Peter Rohr Germany	15	513 0.6×	296 0.3×	86 0.3×	285 1.3×	98 0.6×	25	1.2k
Karin S. Kapp Austria	24	737 0.8×	458 0.5×	475 1.8×	176 0.8×	429 2.7×	69	1.9k

Countries citing papers authored by Elide Matano

Since Specialization

Citations

This map shows the geographic impact of Elide Matano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elide Matano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elide Matano more than expected).

Fields of papers citing papers by Elide Matano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elide Matano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elide Matano. The network helps show where Elide Matano may publish in the future.

Co-authorship network of co-authors of Elide Matano

This figure shows the co-authorship network connecting the top 25 collaborators of Elide Matano. A scholar is included among the top collaborators of Elide Matano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elide Matano. Elide Matano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pellegrino, Sara, et al.. (2024). Coefficient of Variation in Metastatic Lymph Nodes Determined by 18F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of Variation in Primary Tumors. Cancers. 16(2). 279–279. 5 indexed citations

Pellegrino, Sara, Rosa Fonti, Vincenzo Damiano, et al.. (2023). Heterogeneity of Glycolytic Phenotype Determined by 18F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer. Diagnostics. 13(14). 2448–2448. 6 indexed citations

Luongo, Cristina, Maria Angela De Stefano, Raffaele Ambrosio, et al.. (2023). Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone. Thyroid. 33(3). 294–300. 7 indexed citations

Mesolella, Massimo, et al.. (2022). New Therapeutic Strategies in the Treatment of Stomal Recurrence After Total Laryngectomy: Role of Immunotherapy. Ear Nose & Throat Journal. 104(7). NP432–NP440. 2 indexed citations

Maurea, Simone, Ciro Gabriele Mainolfi, Arnaldo Stanzione, et al.. (2022). Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves. Heliyon. 8(1). e08819–e08819. 5 indexed citations

Cennamo, Gilda, Daniela Montorio, A. Farella, et al.. (2022). Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy. Frontiers in Oncology. 11. 754108–754108. 11 indexed citations

D’Ambrosio, Antonio, Pietro De Placido, Liliana Montella, et al.. (2022). The unusual first sign of presentation of renal cell carcinoma: a rare case report. AME Case Reports. 6. 35–35.

Pellegrino, Sara, Rosa Fonti, Luisa Piccin, et al.. (2019). Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer. Annals of Nuclear Medicine. 33(12). 937–944. 38 indexed citations

Attademo, Laura, Stefano De Falco, Mario Rosanova, et al.. (2018). A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy. Medicine. 97(9). e0011–e0011. 3 indexed citations

10.

Nappi, Lucia, V. Damiano, Margaret Ottaviano, et al.. (2015). Correlation between plasmatic levels of vitamin D and testicular cancer. Annals of Oncology. 26. vi58–vi58. 3 indexed citations

11.

Ottaviano, Margaret, V. Damiano, Lucia Nappi, et al.. (2015). Effectiveness of somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors. Annals of Oncology. 26. vi79–vi79. 2 indexed citations

12.

Cella, Chiara Alessandra, Chiara Carlomagno, Florian Lordick, et al.. (2014). Basaloid Squamous Cell Carcinoma: A Rare Tumor at the Esophagogastric Junction and an Unexpected Durable Complete Response to FOLFOX-4. Oncology Research and Treatment. 37(1-2). 55–58. 2 indexed citations

13.

Buonerba, Carlo, Margaret Ottaviano, Piera Federico, et al.. (2014). Capecitabine plus gemcitabine in thymic epithelial tumors: Final analysis of a phase II trial.. Journal of Clinical Oncology. 32(15_suppl). 7528–7528. 6 indexed citations

14.

Fabbrocini, Gabriella, Luigia Panariello, Matilde Pensabene, et al.. (2013). EMPACT Syndrome Associated with Phenobarbital. Dermatitis. 24(1). 37–39. 5 indexed citations

15.

Boni, C., Marcello Tiseo, Luca Boni, et al.. (2012). Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British Journal of Cancer. 106(4). 658–665. 19 indexed citations

16.

Palmieri, Giovannella, Mirella Marino, Carlo Buonerba, et al.. (2011). Imatinib mesylate in thymic epithelial malignancies. Cancer Chemotherapy and Pharmacology. 69(2). 309–315. 40 indexed citations

17.

Carlomagno, Chiara, Gennaro Daniele, Roberto Bianco, et al.. (2011). Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials. Experimental and Therapeutic Medicine. 2(3). 449–455. 3 indexed citations

18.

Tortora, Giampaolo, Fortunato Ciardiello, V. Damiano, et al.. (2002). Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer. Annals of Oncology. 13(3). 392–398. 12 indexed citations

19.

Tagliaferri, Pierosandro, Carmen Barile, Michele Caraglia, et al.. (1998). Daily Low-Dose Subcutaneous Recombinant Interleukin-2 by Alternate Weekly Administration. American Journal of Clinical Oncology. 21(1). 48–53. 19 indexed citations

20.

Bianco, A R, Lucia Del Mastro, Ciro Gallo, et al.. (1991). Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. British Journal of Cancer. 63(5). 799–803. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact